Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexicon Pharmaceuticals (LXRX) Net Income towards Common Stockholders: 2009-2011

Historic Net Income towards Common Stockholders for Lexicon Pharmaceuticals (LXRX) over the last 3 years, with Dec 2011 value amounting to -$116.2 million.

  • Lexicon Pharmaceuticals' Net Income towards Common Stockholders fell 47.16% to -$33.8 million in Q4 2011 from the same period last year, while for Dec 2011 it was -$115.1 million, marking a year-over-year decrease of 16.06%. This contributed to the annual value of -$116.2 million for FY2011, which is 14.19% down from last year.
  • Lexicon Pharmaceuticals' Net Income towards Common Stockholders amounted to -$116.2 million in FY2011, which was down 14.19% from -$101.8 million recorded in FY2010.
  • Lexicon Pharmaceuticals' Net Income towards Common Stockholders' 5-year high stood at -$93.3 million during FY2009, with a 5-year trough of -$116.2 million in FY2011.
  • Moreover, its 3-year median value for Net Income towards Common Stockholders was -$101.8 million (2010), whereas its average is -$103.8 million.
  • Data for Lexicon Pharmaceuticals' Net Income towards Common Stockholders shows a maximum YoY decreased of 14.19% (in 2011) over the last 5 years.
  • Yearly analysis of 3 years shows Lexicon Pharmaceuticals' Net Income towards Common Stockholders stood at -$93.3 million in 2009, then decreased by 9.06% to -$101.8 million in 2010, then decreased by 14.19% to -$116.2 million in 2011.